GoodRx Holdings (GDRX) Other Operating Expenses (2019 - 2026)

GoodRx Holdings has disclosed Other Operating Expenses across 8 years of filings, most recently posting $123.0 million for Q1 2026.

• Other Operating Expenses for Q1 2026 came in at $123.0 million, up 3.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $478.6 million (down 1.39% YoY), and the FY2025 annual result was $470.2 million, down 2.12% from the prior year.
• Other Operating Expenses came in at $123.0 million for Q1 2026 at GoodRx Holdings, up from $119.2 million in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $152.5 million in Q4 2023 to a low of -$41.7 million in Q3 2022.
• The 5-year median for Other Operating Expenses is $118.4 million (2025), against an average of $91.6 million.
• Across the five-year window, Other Operating Expenses tumbled 110.1% in 2022 and soared 7834.74% in 2023, its largest moves.
• GoodRx Holdings' Other Operating Expenses stood at -$2.0 million in 2022, then jumped by 7834.74% to $152.5 million in 2023, then decreased by 17.97% to $125.1 million in 2024, then slipped by 4.71% to $119.2 million in 2025, then increased by 3.17% to $123.0 million in 2026.
• The last three Other Operating Expenses figures came in at $123.0 million (Q1 2026), $119.2 million (Q4 2025), and $118.4 million (Q3 2025), per Business Quant data.